537 related articles for article (PubMed ID: 20333419)
21. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.
Khosla S; Burr D; Cauley J; Dempster DW; Ebeling PR; Felsenberg D; Gagel RF; Gilsanz V; Guise T; Koka S; McCauley LK; McGowan J; McKee MD; Mohla S; Pendrys DG; Raisz LG; Ruggiero SL; Shafer DM; Shum L; Silverman SL; Van Poznak CH; Watts N; Woo SB; Shane E;
J Bone Miner Res; 2007 Oct; 22(10):1479-91. PubMed ID: 17663640
[TBL] [Abstract][Full Text] [Related]
22. [Bisphosphonate-associated osteonecrosis of the jaw].
Abu-Id MH; Açil Y; Gottschalk J; Kreusch T
Mund Kiefer Gesichtschir; 2006 Mar; 10(2):73-81. PubMed ID: 16456688
[TBL] [Abstract][Full Text] [Related]
23. [Bisphosphonate-related osteonecrosis of the jaw].
Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
[TBL] [Abstract][Full Text] [Related]
24. Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients.
Adamo V; Caristi N; Saccà MM; Ferraro G; Arcanà C; Maisano R; Santini D; Tonini G
Expert Opin Pharmacother; 2008 Jun; 9(8):1351-61. PubMed ID: 18473709
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.
Ficarra G; Beninati F
Head Neck Pathol; 2007 Dec; 1(2):132-40. PubMed ID: 20614264
[TBL] [Abstract][Full Text] [Related]
26. Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.
Fleisher KE; Welch G; Kottal S; Craig RG; Saxena D; Glickman RS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):509-16. PubMed ID: 20674404
[TBL] [Abstract][Full Text] [Related]
27. Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases.
Park W; Kim NK; Kim MY; Rhee YM; Kim HJ
Osteoporos Int; 2010 Mar; 21(3):527-33. PubMed ID: 19484166
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients.
Madrid C; Bouferrache K; Abarca M; Jaques B; Broome M
Oral Oncol; 2010 Jun; 46(6):468-70. PubMed ID: 20452814
[TBL] [Abstract][Full Text] [Related]
29. Recent Clinical Evidence in Bisphosphonate-related Osteomyelitis of the Jaw: Focus on Risk, Prevention and Treatment.
Yamazaki T; Takahashi K; Bessho K
Rev Recent Clin Trials; 2014; 9(1):37-52. PubMed ID: 24758539
[TBL] [Abstract][Full Text] [Related]
30. Osteonecrosis of the Torus Palatinus in the Setting of Long-Term Oral Bisphosphonate Use--A Case Report.
Ryan JL; Larson E
S D Med; 2016 Jan; 69(1):23-5. PubMed ID: 26882578
[TBL] [Abstract][Full Text] [Related]
31. Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma.
Goranova-Marinova VS; Pechalova-Petrova PF; Goranov SG
Folia Med (Plovdiv); 2009; 51(4):53-7. PubMed ID: 20232660
[TBL] [Abstract][Full Text] [Related]
32. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
Chaudhry AN; Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
[TBL] [Abstract][Full Text] [Related]
33. National Survey on Bisphosphonate-Related Osteonecrosis of the Jaws in Japan.
Shibahara T; Morikawa T; Yago K; Kishimoto H; Imai Y; Kurita K
J Oral Maxillofac Surg; 2018 Oct; 76(10):2105-2112. PubMed ID: 29746838
[TBL] [Abstract][Full Text] [Related]
34. [Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice].
Dannemann C; Grätz KW; Zwahlen RA
Schweiz Monatsschr Zahnmed; 2008; 118(2):113-23. PubMed ID: 18361180
[TBL] [Abstract][Full Text] [Related]
35. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
Chu V; ;
Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
[TBL] [Abstract][Full Text] [Related]
36. [Osteonecrosis of the jaws by long term therapy with bisphosphonates].
Piesold JU; Al-Nawas B; Grötz KA
Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697
[TBL] [Abstract][Full Text] [Related]
37. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.
Baillargeon J; Kuo YF; Lin YL; Wilkinson GS; Goodwin JS
Ann Pharmacother; 2011 Oct; 45(10):1199-206. PubMed ID: 21954448
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
[TBL] [Abstract][Full Text] [Related]
39. [Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].
Dehari H; Tomihara K; Ueda M; Shimanishi M; Ono M; Sasaki T; Igarashi T; Shiratori K; Abe M; Ogi K; Nakamori K; Miyazaki A; Nagai I; Hiratsuka H
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2587-92. PubMed ID: 20009460
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
